TNF Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
TNF Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q1 2024.
  • TNF Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $9.34K, a 48.8% decline year-over-year.
  • TNF Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $74.6K, a 1.69% decline from 2022.
  • TNF Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $75.9K, a 62.4% decline from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $9.34K -$8.89K -48.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $18.2K +$1.8K +10.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $16.4K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.